Listen in as a general cardiologist, surgeon, and interventionalist delve into the latest evidence—including the Evolut™ TAVR 5-Year Low Risk data and SMART Trial 2-Year update—to guide appropriate treatment decisions for patients with severe symptomatic aortic stenosis.
Duke University Health System has integrated Barostim into its comprehensive heart failure program. For patients with heart failure with reduced ejection fraction (HFrEF), Barostim is a device therapy that works with drug therapies to target the neurohormonal pathways responsible for heart failure progression and symptoms. Listen in as an advanced heart failure specialist discusses patient selection and post-implant management, the implant procedure, patient care pathways, and how Duke has incorporated Barostim into their system.
The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.
Diagnosing female patients with coronary artery disease (CAD) has many challenges. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating these difficulties, and the guidelines and pathways that help with diagnosis and management of women with suspected CAD.
Most advancements in electrophysiology technology are small and incremental, but the experts at Texas Cardiac Arrhythmia Institute in Austin, TX, were quick to see distinct advantages when they started using the latest iteration of radio frequency ablation, the QDOT MICRO™ Catheter.
Learn from experts retooling interventional programs how to keep patients and staff safe as the pandemic is evolving. Gain practical insight on how health systems are prioritizing COVID-19 and non-COVID-19 patients and dealing with backlogged cases, minimizing the need for additional ICU beds, triaging clinical needs along with essential personnel plus resources, and expanding lines of communication pre-and post-procedure with patients and families.
Join a panel of experts to hear how technologies like graphic processing units (GPUs), cloud storage and artificial intelligence are changing the practice of radiology.
With all the buzz on AI at RSNA we wanted to cut through some of the hype and learn more about FDA approved AI solutions. One such solution is making news for stroke workflow and the company we spoke with already has over 300 health system installs in the US.
Listen in on our conversation with Ashley Clary, Vice President of Imaging Services at Ochsner, and Geoff Clemmons, Product Marketing Manager for Vital.
Learn from four leading cardiologists on the movement of TAVR into this low-risk patient population, how hospitals are increasing awareness among physicians and patients and the importance of connecting patients with heart teams.
This webinar is a must-see use case for radiology practice and hospital leaders seeking to more tightly share and integrate data to improve operations, starting with billing and radiologist workflow.
Communication failures for diagnostic imaging results can have serious consequences for patient care–and can result in costly medical malpractice cases. Join us and see how how radiologists can be freed from unproductive contact attempts.
With a need to have access to clinical images across the health system, some hospitals and health systems are blazing a trail to add digital pathology to the mix. See how University Hospitals’ pathology department has gotten pathologists fluent and confident in digital pathology. And how their team has united pathology PACS with radiology PACS for breast rad-path MDT meetings.